Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in
In the Interim... artwork

Podcast

In the Interim...

Berry

Science · 85 episodes
  • Website
Follow

Guests who follow get this show's guest call alerts.

Subscribe+ Add a credit

A podcast on statistical science and clinical trials.Explore the intricacies of Bayesian statistics and adaptive clinical trials. Uncover methods that push beyond conventional paradigms, ushering in data-driven insights that enhance trial outcomes while ensuring safety and efficacy. Join us as we dive into complex medical challenges and regulatory landscapes, offering innovative solutions tailored for pharma pioneers. Featuring expertise from industry leaders, each episode is crafted to provide clarity, foster debate, and challenge mainstream perspectives, ensuring you remain at the forefront...

Listen on
  • Apple Podcasts
  • Find on Spotify
EpisodesPeoplePostsSubscribe

Is this your show? Claim this page

Information

Creator
Berry
Category
Science
Years active
2025 to 2026
Episodes
85
Copyright
© 2025 Berry Consultants
Show website
berryconsultants.com

Sign in to suggest a network

PodCred

The people behind this show

People get invited back because someone remembered they were great.

PodCred is the verified record of who made this show. A credit here means people who were there confirmed the work.

Hosts

  • Scott BerryHost, 62 episodesFeed-stated

Guests

  • Don BerryGuest, 5 episodesFeed-stated

Who is on this show?

Think of the guest you still think about. The producer who makes the host sound smart. The editor who saves every episode. If a name is missing here, that person is invisible everywhere.

Add a credit

Episodes

85 episodes
85 episodes
  1. Can Borrowing Ever Increase Power?

    Nov 16, 202625 minAudio

    In this episode of "In the Interim…", Dr. Kert Viele, Director of Research at Berry Consultants, takes up a requested topic: published results showing that Bayesian borrowing of historical control data cannot increase...

    Credit the people on this episode

  2. Mailbag: Learning Healthcare, Multiplicities, and the Pace of Innovation

    Nov 9, 202647 minAudio

    In this mailbag episode of "In the Interim…", Dr. Scott Berry answers two listener questions and weighs in on the pace of innovation in clinical trial science. Asked what infrastructure a learning healthcare system...

    Credit the people on this episode

  3. Reflecting on EMA Reflections on Platform Trials

    Nov 2, 202644 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry and Dr. Kert Viele, Director of Research at Berry Consultants, review the European Medicines Agency's draft reflection paper on methodological aspects in...

    Credit the people on this episode

  4. Statistical Methodology Groups in the Pharmaceutical Industry

    Oct 19, 202656 minAudio

    In this episode of "In the Interim…", Scott Berry is joined by Jenny Devenport and Kaspar Rufibach of Merck Group, co-authors of the EFSPI Statistical Methodology Leaders paper "Statistical Methodology Groups in the...

    Credit the people on this episode

  5. A Discussion on Virtual Controls

    Oct 12, 202647 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry shares the framework he presented at a CSRC regulatory science hackathon on digital twins and synthetic controls in cardiovascular clinical trials. He separates...

    Credit the people on this episode

  6. Clinical Trial Arenas: Direct Communication to Patients

    Sep 28, 202643 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry recounts a presentation he gave to the Speak Foundation, a patient organization focused on limb-girdle muscular dystrophy and makes the case for master protocols...

    Credit the people on this episode

  7. Science Coaching With Alun Bedding

    Sep 21, 202645 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry talks with Dr. Alun Bedding, a professional certified coach and statistician who spent decades in pharmaceutical statistics, including as global head of statistical...

    Credit the people on this episode

  8. The CHIPS Trial: Bayesian Adaptive Trial in JAMA

    Sep 14, 202646 minAudio

    In this episode of “In the Interim…,” Dr. Scott Berry talks with Dr. Roger Lewis, Dr. Anna McGlothlin, and Dr. Nick Berry - all co-authors on the CHIPS trial results recently published in JAMA (Spinella et al., August...

    Credit the people on this episode

  9. NFL Study of CTE: The Issues

    Sep 7, 202639 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry examines three recent health-research headlines through a statistician's lens: an Adventist Health Study-2 analysis claiming eggs reduce Alzheimer's risk, an Emory...

    Credit the people on this episode

  10. Talkin' 'bout Sweet Time

    Aug 31, 202647 minAudio

    In this episode of "In the Interim...", Dr. Scott Berry dissects prevailing concepts of “clinically meaningful difference” in clinical trials focusing on progressive diseases. Through detailed examples from pancreatic...

    Credit the people on this episode

  11. Mammograms: Death Threats, Hillary Clinton and Lead-Time Bias

    Aug 17, 20261 hr 6 minAudio

    In this episode of "In the Interim…", Dr. Don Berry provides a detailed account of co-chairing the 1997 NIH consensus development conference on mammography for women in their 40s. His conversation with Dr. Scott Berry...

    Credit the people on this episode

  12. REMAP-CAP Results: Oseltamivir in Critically-Ill Influenza Patients

    Aug 10, 202652 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry speaks with Dr. Srinivas Murthy, Dr. Thomas Hills, and Dr. Lindsay Berry about the REMAP-CAP trial results on oseltamivir in critically ill influenza patients. The...

    Credit the people on this episode

  13. ICECAP: The Results

    Aug 5, 202655 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry leads a comprehensive discussion of the ICECAP trial results with four Principal Investigators: Dr. Will Meurer (Professor, Emergency Medicine and Neurology,...

    Credit the people on this episode

  14. Failure of the Proportional Odds is the Result

    Aug 3, 202640 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry and Dr. Elizabeth Lorenzi systematically examine the analytic pitfalls in recent acute ischemic stroke trials, especially the implications of violating the...

    Credit the people on this episode

  15. Adaptive Design Actions Matrix

    Jul 27, 202631 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry challenges the widely held belief that any interim look at trial data obligates an alpha adjustment. By constructing a two-by-two matrix: interim data...

    Credit the people on this episode

  16. A Visit With Tim Berry

    Jul 20, 202644 minAudio

    In this episode of "In the Interim…," Dr. Scott Berry interviews Tim Berry, co-founder of Blend360, detailing a career that demonstrates the practical application of statistical and analytical methods within large-scale...

    Credit the people on this episode

  17. Fairness in Soccer and Clinical Trials

    Jul 13, 202635 minAudio

    In this episode of "In the Interim...", Dr. Scott Berry investigates the practical meaning of fairness by connecting a controversial World Cup soccer ruling to foundational questions in clinical trial statistics. Scott...

    Credit the people on this episode

  18. Bias in Stopping Trials Early

    Jul 6, 202639 minAudio

    On the latest episode of "In the Interim...", Dr. Scott Berry and Dr. Kert Viele deliver a focused, technical analysis of statistical bias when stopping trials early. This episode clarifies the definition of bias,...

    Credit the people on this episode

  19. A Statistician Reads JAMA: A Futile Issue

    Jun 22, 202646 minAudio

    On the latest episode of "In the Interim…", Dr. Scott Berry provides an empirical examination of two recent JAMA trials: TRACK (low-dose rivaroxaban in advanced kidney disease) and VICTORY (IV vitamin C in severe burn...

    Credit the people on this episode

  20. Response-Adaptive Randomization in Clinical Trials

    Jun 15, 202647 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry and Dr. Kert Viele examine response-adaptive randomization (RAR) in clinical trials, dissecting its statistical rationale, common criticisms, and implementation...

    Credit the people on this episode

  21. REMAP-CAP: The Origin

    Jun 8, 202653 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry explores the origins of REMAP-CAP with Prof. Steve Webb, former chair of the REMAP-CAP International Trial Steering Committee. This episode examines how pandemic...

    Credit the people on this episode

  22. Fighting Time in Adaptive Trials

    Jun 1, 202656 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry explores the challenge of protracted endpoint timelines in adaptive clinical trials and the statistical strategies used to increase the rate of actionable...

    Credit the people on this episode

  23. ICECAP: The Adaptive Design

    May 25, 202651 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry is joined by Dr. Will Meurer, professor of Emergency Medicine and Neurology at the University of Michigan, for an in-depth discussion of the ICECAP trial’s adaptive...

    Credit the people on this episode

  24. Multi-Platform RCT

    May 18, 202633 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry details the design, execution, and results of the multi-platform randomized clinical trial (mpRCT) pioneered during the COVID-19 pandemic. He describes how...

    Credit the people on this episode

  25. Sports and Clinical Trials: The 1927 Yankees, 15 Tarzans, and Modern Athletes

    May 11, 202651 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry examines the analytical challenges of comparing performance across eras in both sports and clinical research. Drawing from statistically robust family debates and...

    Credit the people on this episode

  26. AI @ Berry

    May 4, 202651 minAudio

    In the 60th episode of “In the Interim…”, Dr. Scott Berry, Dr. Nick Berry, and Dr. Joe Marion discuss how Berry Consultants uses AI in clinical trial design and software development. The conversation addresses current...

    Credit the people on this episode

  27. Drug Development and Sports: The 10-Run Rule and Futility

    Apr 27, 202652 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry and Dr. Nick Berry investigate how futility in clinical trials and stopping rules in sports illuminate very similar decision problems, albeit with very different...

    Credit the people on this episode

  28. ICH-E20, Regulators, and False Choices

    Apr 20, 202641 minAudio

    In this episode of "In the Interim…", host Dr. Scott Berry undertakes a detailed, methodical critique of ICH-E20 draft guidance language as applied to adaptive clinical trial design. Focusing on an innocuous but...

    Credit the people on this episode

  29. PANTHER: A Phase 2 International Platform Trial in ARDS

    Apr 13, 202653 minAudio

    In this episode of "In the Interim…" Dr. Scott Berry is joined by Professors Victoria Cornelius, Danny McAuley, and Anthony Gordon, for a technical review of the PANTHER trial - an international, Phase 2 adaptive...

    Credit the people on this episode

  30. A Visit with Byron Gajewski: KUMC, Innovative Trial Designs, the HOBIT Trial

    Apr 6, 202640 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry connects with Dr. Byron Gajewski, professor of biostatistics and data science at the University of Kansas Medical Center (KUMC), for a detailed discussion on the...

    Credit the people on this episode

  31. A Visit with Stephen Senn: Time, Concurrent Controls, and the Bayesian Guidance

    Mar 30, 202647 minAudio

    In this episode of "In the Interim...", Dr. Scott Berry hosts Dr. Stephen Senn, award-winning statistician and author, for a discussion on advanced challenges in adaptive and platform trial methodology. Senn draws on...

    Credit the people on this episode

  32. Making Sense of Hierarchical Composites

    Mar 23, 202654 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry is joined by statisticians Dr. Amy Crawford, Dr. Cora Allen-Savietta, and Dr. Jessica Overbey for a technical deep dive into hierarchical composite endpoints and the...

    Credit the people on this episode

  33. The SNAP Trial with Professors Tong and Davis

    Mar 16, 202654 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry interviews Professors Steven Tong and Josh Davis about the SNAP platform trial for Staphylococcus aureus bacteremia. The discussion covers SNAP’s rationale,...

    Credit the people on this episode

  34. Bayesian Borrowing in Phase 3 Trials

    Mar 9, 202647 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry and Dr. Kert Viele examine Bayesian borrowing in Phase 3 clinical trials, focusing on statistical handling of prior information and real-world FDA interactions. The...

    Credit the people on this episode

  35. The Art of Storytelling with Shaun Cassidy

    Mar 2, 202652 minAudio

    In Episode 51 of "In the Interim…", Dr. Scott Berry interviews writer, producer, and performer Shaun Cassidy to examine the practical elements of storytelling that matter in scientific and statistical communication....

    Credit the people on this episode

  36. The Fallacy of Ordinal Endpoints

    Feb 23, 202644 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry and Dr. Lindsay Berry investigate the statistical foundations and clinical implications of analyzing ordinal endpoints, drawing on experience from major stroke and...

    Credit the people on this episode

  37. Mr. Berry Goes to Washington

    Feb 16, 202647 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry marks the podcast’s one-year anniversary, sharing listener metrics, watch data, and regional engagement. He then delivers a step-by-step analysis of the FDA meeting...

    Credit the people on this episode

  38. Platform Trial in Orthopaedic Surgery

    Feb 9, 202641 minAudio

    Dr. Nathan O’Hara (University of Maryland), Dr. Gerard Slobogean (UC Irvine), and Dr. Sheila Sprague (McMaster University) describe the launch and design of the Musculoskeletal Adaptive Platform Trial (MAPT) - the first...

    Credit the people on this episode

  39. A Visit with Michael Harhay

    Feb 2, 202639 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry speaks with Dr. Michael Harhay, Associate Professor at the University of Pennsylvania and Director of the Center for Clinical Trials Innovation. The conversation...

    Credit the people on this episode

  40. The FDA Bayesian Guidance

    Jan 26, 202643 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry and Dr. Kert Viele deliver a quick reaction to the FDA’s draft guidance on Bayesian statistics for clinical trials of drugs and biologics. Their assessment addresses...

    Credit the people on this episode

  41. Path 2 Parkinson's Prevention with Drs. Simuni and Wendelberger

    Jan 19, 202642 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry is joined by Dr. Tanya Simuni, Arthur C. Nielsen Jr. Professor of Neurology and Director of the Parkinson’s Disease and Movement Disorders Center at Northwestern...

    Credit the people on this episode

  42. Statistical Communication

    Jan 12, 202642 minAudio

    In this episode of “In the Interim…,” host Dr. Scott Berry examines the challenge of communicating complex statistical concepts to non-statistical audiences. Drawing from firsthand experiences in agriculture,...

    Credit the people on this episode

  43. The Rumor of One Trial for Substantial Evidence

    Dec 29, 202540 minAudio

    In this episode of "In the Interim…", host Dr. Scott Berry and frequent co-host Dr. Kert Viele, Senior Statistical Scientist at Berry Consultants, analyze the potential shift in FDA regulatory policy from requiring two...

    Credit the people on this episode

  44. Communication for Scientists: A Discussion with Jenny Devenport

    Dec 22, 202540 minAudio

    In this episode of "In the Interim…", Dr. Jenny Devenport, Global Head of Methods, Collaboration, and Outreach at Roche, joins Dr. Scott Berry for a detailed discussion on career evolution, statistical culture, and...

    Credit the people on this episode

  45. Navigating the Arena: Platform Trials

    Dec 15, 202550 minAudio

    In this episode of "In the Interim…", Dr. Scott Berry delivers a metaphoric critique of single-question trial infrastructure through the sports arena analogy, illustrating the cost, patient burden, and data inefficiency...

    Credit the people on this episode

Show moreShowing 45 of 85

Posts

No posts yet. Posts In the Interim... shares on PodSubs, and what it publishes on Substack, YouTube and its own site, will show here.

Be the first to rate this show

Subscribe

Be on the front line of the show

Everything In the Interim... sends its own people, first. Resources, announcements, behind the scenes, events, and giveaways, straight from the host. No account needed.

  • The resources the host shares with subscribers
  • Announcements before anyone else hears
  • Behind the scenes from the team
  • Events, invitations, and giveaways
  • Only what the host sends, nothing else
How often

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Report this show

Similar shows

  • Huberman Lab artwork

    Huberman Lab

    Also in Science

    294 episodes

    Updated Nov 21, 2026

  • Stuff To Blow Your Mind artwork

    Stuff To Blow Your Mind

    Also in Science

    3,259 episodes

    Updated Nov 21, 2026

  • Something You Should Know artwork

    Something You Should Know

    Also in Science

    1,372 episodes

    Updated Nov 21, 2026

  • Meteor artwork

    Meteor

    Also in Science

    65 episodes

    Updated Nov 21, 2026

  • Bigfoot Eyewitness Radio artwork

    Bigfoot Eyewitness Radio

    Also in Science

    569 episodes

    Updated Nov 21, 2026

  • Authentic Biochemistry artwork

    Authentic Biochemistry

    Also in Science

    1,362 episodes

    Updated Nov 21, 2026

  • Health Lab artwork

    Health Lab

    Also in Science

    543 episodes

    Updated Nov 20, 2026

  • The Science Show artwork

    The Science Show

    Also in Science

    252 episodes

    Updated Nov 20, 2026